Form 8-K - Current report:
SEC Accession No. 0001140361-21-036328
Filing Date
2021-11-03
Accepted
2021-11-03 11:15:24
Documents
15
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10030336_8k.htm   iXBRL 8-K 25499
2 EXHIBIT 99.1 brhc10030336_ex99-1.htm EX-99.1 350436
6 image00001.jpg GRAPHIC 803
7 image00002.jpg GRAPHIC 7699
  Complete submission text file 0001140361-21-036328.txt   546999

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20211103.xsd EX-101.SCH 3932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20211103_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20211103_pre.xml EX-101.PRE 16048
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10030336_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 211374247
SIC: 2834 Pharmaceutical Preparations